SLN Silence Therapeutics PLC Yalpi foyda bo'yicha marjinallik

Silence Therapeutics PLC (SLN) korporativ emblemasi va logotipi

Silence Therapeutics kompaniyasi yuqori narxlarni belgilash imkonini beruvchi noyob RNK dori vositalarini yetkazib berish tizimiga asoslangan. Sanoat gigantlari bilan hamkorlikdagi klinik dasturlarning diversifikatsiyasi moliyaviy risklarni kamaytiradi, ekologik ta'sir esa bioxavfli chiqindilarni yo'q qilishning qat'iy qoidalari bilan cheklangan. Marjinal yalpi foyda ushbu strategiyaning samaradorligini tasdiqlaydi, bunda 2.50 joriy parametr qiymati bo'lib xizmat qiladi.

Yalpi foyda bo'yicha rentabellik: Silence Therapeutics (SLN) 21.06.2023 - 20.11.2026 uchun

silence-therapeutics.com (SLN) moliyaviy va bozor koʻrsatkichlari kesimi

- bozor qiymati va tahlilchilarning maqsadli prognozi:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Fundamental baholash:SLN, Silence Therapeutics PLC
Silence Therapeutics yetakchi tovari

Yalpi foyda marjasi mahsulotni yaratishning bevosita xarajatlarini chegirib tashlagandan keyin qolgan daromad qismini aniqlash orqali ishlab chiqarish samaradorligini o'lchaydi. Yalpi foyda foizini tahlil qilish Silence Therapeutics (SLN) mRNA interferensiya ekotizimining monetizatsiyasi kardiologik va ghematologik patologiyalar uchun genlarni jimjitish usullarini ishlab chiqish xarajatlarini qanday qoplaydigini baholash imkonini beradi, bu esa ushbu biotexnologik platformaning operatsion barqarorligini baholash uchun juda muhimdir.

Asosiy raqobatchilar

Yalpi foyda bo'yicha rentabellik Tempus AI Inc|QGEN (Qiagen NV) - Yalpi marja|Yalpi foyda bo'yicha rentabellik Ionis Pharma (IONS)|Yalpi rentabellik Repligen Corp (RGEN)|RNA - Yalpi foyda marjasi|crisprtx.com - Yalpi foyda bo'yicha rentabellik|Yalpi foyda normasi WGS|RARE - Yalpi rentabellik|Beam Tx (BEAM) - Yalpi foyda bo'yicha rentabellik|SRPT (Sarepta Therapeutics Inc) - Yalpi foyda bo'yicha rentabellik|TWST: Yalpi foyda koeffitsiyenti|TXG (10xgenomics.com) - Yalpi marja|NTLA (Intellia Therapeutics, Inc.) - Yalpi foyda koeffitsiyenti|Yalpi rentabellik Stoke Corp (STOK)|Yalpi foyda bo'yicha sotuv rentabelligi BioLife|Yalpi marja WVE (Wave Life Sciences Ltd)|MAZE: Sotuvning yalpi rentabelligi|Sionna Therapeutics, Inc. - Yalpi marja|Yalpi foyda normasi PRME (Prime Medicine Inc)|TSHA (Taysha Gene Therapies, Inc.) - Yalpi foyda bo'yicha rentabellik|QURE - Yalpi foyda bo'yicha sotuv rentabelligi|MGTX (MeiraGTx Corp) - Yalpi marja|Yalpi foyda marjasi REGENXBIO Inc. RGNX|Yalpi rentabellik Solid Biosciences (SLDB)|Ocugen Corp - Sotuvning yalpi rentabelligi|Yalpi rentabellik Pacific Biosciences PACB|Yalpi foyda koeffitsiyenti BNTC (Benitec)|Design Corp - Yalpi marja|Rocket Pharmaceuticals - Yalpi foyda koeffitsiyenti|Sotuvning yalpi rentabelligi 4D Molecular Therapeutics, Inc.|Yalpi foyda marjasi Lexeo Therapeutics (LXEO)|KRRO (Korro Bio, Inc.) - Yalpi marja|Yalpi foyda marjasi Editas EDIT|Yalpi rentabellik ProQR Therapeutics NV (PRQR)|Codexis - Sotuvning yalpi rentabelligi|Yalpi rentabellik Sangamo SGMO|NAUT: Sotuvning yalpi rentabelligi|MGX: Yalpi foyda bo'yicha rentabellik|Yalpi foyda marjasi Precision BioSciences|GBIO (generationbio.com) - Yalpi foyda bo'yicha rentabellik|Yalpi foyda marjasi boundlessbio.com (BOLD)|XCUR (exicuretx.com) - Yalpi marja|Sotuvning yalpi rentabelligi IMNN (Imunon, Inc.)|Yalpi marja PHIO|MBIO - Yalpi foyda marjasi|Yalpi marja RNAZ (TransCode Therapeutics)|bionanogenomics.com (BNGO) - Yalpi foyda marjasi|Applied DNA - Yalpi marja|Yalpi foyda marjasi Bluebird Bio|ImmunoPrecise (IPA) - Yalpi rentabellik|Yalpi foyda bo'yicha marjinallik OMGA (Omega)|Yalpi rentabellik Singular Genomics Systems|Yalpi foyda marjasi regulusrx.com RGLS|Yalpi rentabellik Syros Pharmaceuticals Inc. (SYRS)|Yalpi foyda bo'yicha sotuv rentabelligi Codex DNA|Yalpi rentabellik TRACON TCON|Unity Biotechnology, Inc - Yalpi rentabellik